XenoSite

Adenosine

CHEBI
Phase 1ReactivityEpoxidationQuinonationN-DealkylationUGT Conjugation
Adenosine N-Dealkylation prediction

(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone

CHEBI
(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone stable oxygenation prediction
(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone unstable oxygenation prediction
(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone dehydrogenation prediction
(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone reduction prediction
(3<i>s</i>,4<i>r</i>,5<i>r</i>)-3,4-dihydroxy-5-(hydroxymethyl)dihydro-2(3<em>h</em>)-furanone hydrolysis prediction

Beta-l-lyxo-pentofuranose

CHEBI
hydrogenation · 0.15
Beta-l-lyxo-pentofuranose
Probability scale from 0.0 to 1.0